BioELife Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Greg Rotelli

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	13.7yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	6.9yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Greg Rotelli's remuneration changed compared to BioELife's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2019	n/a	n/a	-US$590k
Jun 30 2019	n/a	n/a	-US$504k
Mar 31 2019	n/a	n/a	-US$207k
Dec 31 2018	US$24k	US$24k	-US$337k

Compensation vs Market: Insufficient data to establish whether Greg's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Greg's compensation with company performance.

CEO

Greg Rotelli (64 yo)

13.7yrs

Tenure

US$24,000

Compensation

Mr. Gregory C. Rotelli, also known as Greg, has been Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary of Nudg Media Inc since April 23, 2015. Mr. Rotelli has been the Ch...

Board Members

Name	Position	Tenure	Compensation	Ownership
Gregory Rotelli	CEO, President	13.7yrs	US$24.00k	no data
Eric Allison	Independent Director	8.9yrs	no data	no data
Todd Ellison	Member of Advisory Board	10.9yrs	no data	no data
Michael Terpin	Member of Advisory Board	4.8yrs	no data	no data
Susan Raffy	Member of Advisory Board	4.8yrs	no data	no data
William Marciniak	Member of Advisory Board	4.8yrs	no data	no data

6.9yrs

Average Tenure

66yo

Average Age

Experienced Board: LITH's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 15:17
End of Day Share Price	2025/01/07 00:00
Earnings	2019/09/30
Annual Earnings	2018/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioELife Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution